The tumor from this patient is mismatch repair deficient (MMRD), with microsatellite instability (MSI‐H), negative MLH1/PMS2 immunohistochemistry and with MLH1 promoter hypermethylation (OMIM #120436). Here, PMS2 is linked to neoplasm.